Overview

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
0
Participant gender:
Female
Summary
A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:

- Clinically significant stress urinary incontinence

Exclusion Criteria:

- History or evidence of any relevant confounding urological or neurological disease